UK 66914;N-[4-[1-Hydroxy-2-[4-(4-pyridinyl)piperazino]ethyl]phenyl]methanesulfonamide;N-(4-{1-hydroxy-2-[4-(pyridin-4-yl)piperazin-1-yl]ethyl}phenyl)methanesulfonamide
UK-66914 is a class III antiarrhythmic agent that specifically targets the delayed rectifier potassium current (I_K). It is designed to prolong the action potential duration (APD) and increase the cardiac refractory period, thereby potentially terminating reentrant mechanisms in arrhythmias without causing the severe side effects associated with other antiarrhythmic drugs that affect sodium (Na+) and calcium (Ca2+) currents.